1 Min Read
Oct 31 (Reuters) - U.S. Food and Drug Administration:
* U.S. Food and Drug Administration grants accelerated approval to Astrazeneca Pharmaceuticals LP's Calquence Source text: (bit.ly/2gZIgqW) Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.